July 23 (Reuters) - Medline Industries is considering an

initial public offering that could fetch a valuation of $50

billion for the medical supplies company, Bloomberg News

reported on Tuesday.

The company and its private equity owners are already in

early-stage talks with banks regarding a potential listing as

soon as the spring of 2025, the report said, citing people

familiar with the matter.

Medline did not immediately respond to a Reuters request for

comment.

The U.S. IPO market has shown signs of a rebound in 2024,

after two sub-par years fueled by high interest rates.

However, investor reception has been mixed toward new

offerings. Shares of healthcare payments company Waystar ( WAY )

, which debuted on Nasdaq last month, are trading above

their IPO price while shares of Chinese electric-vehicle maker

have slipped below their offer price.

Blackstone, Carlyle Group ( CG ) and Hellman &

Friedman agreed to buy a majority stake in Medline in 2021,

valuing the company at $30 billion excluding debt.

Blackstone and Carlyle did not immediately respond to

Reuters requests for comment, while Hellman declined to comment.

Northfield, Illinois-based Medline is one of the largest

privately held manufacturers and distributors of medical

supplies such as surgical equipment, gloves, and laboratory

devices used by hospitals around the world.